Boxes containing vials of the Moderna Covid-19 vaccine are on display at the Kedren Community Health Center on January 25, 2021 in Los Angeles, California.
Patrick T. Fallon | UKTN | Getty Images
Moderna’s Covid-19 vaccine can remain stable at temperatures found in refrigerators for 3 months, the company said on Thursday, citing new data.
The mRNA vaccine is currently approved to be stored in the refrigerator between 36 and 46 degrees Fahrenheit for up to 30 days and up to seven months in the freezer at minus 4 degrees Fahrenheit, according to the company.
But Moderna said Thursday it now has data that could support a three-month refrigerated shelf life for the vaccine.
If cleared by the Food and Drug Administration, the new storage temperature could “facilitate easier distribution to doctor’s offices and other smaller establishments,” the company wrote in a press release.
He also said he was working on new formulations of his vaccine that could extend the shelf life of refrigerated injections even further.
Moderna’s Covid vaccine is one of three vaccines authorized in the United States. The vaccine from Pfizer and BioNTech can be stored at refrigerated temperatures for up to five days, according to the Centers for Disease Control and Prevention. Johnson & Johnson vaccine can be stored in a regular refrigerator for up to three months.
For public officials, J & J’s permission to shoot was a blessing as it could be used in hard-to-reach places that may not have reliable refrigeration, such as tribal lands, poorer neighborhoods as well as communities. rural and border areas.
Moderna’s update comes weeks after the FDA announced it had given the company permission to ramp up production of its Covid vaccine by allowing it to fill a single vial with up to 15 doses. It was previously authorized for 10 doses, enough to inoculate five people since the vaccine requires two injections given one month apart.
Separately, the company announced Thursday that it was increasing its minimum production target for Covid vaccines for 2021 to 800 million doses, from 700 million.